Michael Cordonnier's most recent trade in Carlsmed Inc was a trade of 197,855 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2026 | 197,855 | 160,567 | - | - | Stock Option (Right to Buy) | |
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.33 per share. | 02 Mar 2026 | 197,855 | 1,554,501 | - | 0.3 | 66,281 | Common Stock |
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 13.29 per share. | 02 Mar 2026 | 197,855 | 1,356,646 | - | 13.3 | 2,629,889 | Common Stock |
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 02 Mar 2026 | 160,567 | 1,517,213 | - | 0.3 | 53,790 | Common Stock |
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2026 | 160,567 | 0 | - | - | Stock Option (Right to Buy) | |
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2026 | 33,264 | 191,692 | - | - | Stock Option (Right to Buy) | |
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.35 per share. | 02 Mar 2026 | 33,264 | 1,550,477 | - | 4.4 | 144,765 | Common Stock |
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 117,316 | 1,356,646 | - | 0 | Common Stock | |
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2025 | 142,857 | 726,235 | - | - | Stock Options (Right to Buy) | |
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2025 | 3,612 | 1,239,330 | - | - | Common Stock | |
| Carlsmed Inc | Michael Cordonnier | Director, CEO, President | 22 Jul 2025 | 3,612 | 0 | - | - | Series B Preferred Stock |